Skye Bioscience Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Skye Bioscience's estimated annual revenue is currently $1.6M per year.(i)
  • Skye Bioscience's estimated revenue per employee is $77,500

Employee Data

  • Skye Bioscience has 20 Employees.(i)
  • Skye Bioscience grew their employee count by -5% last year.

Skye Bioscience's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Skye Bioscience?

Skye Bioscience (OTC: SKYE) is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. The Company's lead program, SBI-100 OE, is focused on developing a treatment for glaucoma, the world's leading cause of irreversible blindness.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$1.6M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M20-13%N/A
#2
$2.9M20-13%N/A
#3
$2M20N/AN/A
#4
$2M20-5%N/A
#5
$1.6M20-47%$22.9M